Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

May 31, 2006

Conditions
Atrial Fibrillation
Interventions
DRUG

AZD7009, no generic name available

Trial Locations (32)

Unknown

Research Site, Esbjerg

Research Site, Hellerup

Research Site, Hvidovre

Research Site, Svendborg

Research Site, Helsinki

Research Site, Oulu

Research Site, Aachen

Research Site, Bad Berka

Research Site, Brandenburg

Research Site, Hamburg

Research Site, Magdeburg

Research Site, Münster

Research Site, Budapest

Research Site, Cegléd

Research Site, Kecskemét

Research Site, Szentes

Research Site, Székesfehérvár

Research Site, Groningen

Research Site, Maastricht

Research Site, Stadskanaal

Research Site, Oslo

Research Site, Rud

Research Site, Tromsø

Research Site, Trondheim

Research Site, Bytom

Research Site, Opole

Research Site, Ruda Śląska

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Linköping

Research Site, Örebro

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY